[HTML][HTML] Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends

MS Matter, T Decaens, JB Andersen… - Journal of …, 2014 - Elsevier
Mechanistic target of rapamycin (mTOR) regulates cell growth, metabolism and aging in
response to nutrients, cellular energy stage and growth factors. mTOR is frequently up …

[HTML][HTML] Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway

B Li, J Li, WW Xu, XY Guan, YR Qin, LY Zhang, S Law… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Esophageal cancer is the sixth most common cause of cancer-related deaths worldwide.
Novel therapeutic intervention is urgently needed for this deadly disease. The functional role …

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

J Polivka Jr, F Janku - Pharmacology & therapeutics, 2014 - Elsevier
Aberrations in various cellular signaling pathways are instrumental in regulating cellular
metabolism, tumor development, growth, proliferation, metastasis and cytoskeletal …

Inhibition of the PI3K/AKT/mTOR pathway in solid tumors

PM LoRusso - Journal of clinical oncology, 2016 - ascopubs.org
The phosphoinositide 3-kinase (PI3K) pathway plays an integral role in many cellular
processes and is frequently altered in cancer, contributing to tumor growth and survival …

[HTML][HTML] PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application

P Xia, XY Xu - American journal of cancer research, 2015 - ncbi.nlm.nih.gov
Cancer stem cells (CSCs) are a subpopulation of tumor cells that possess unique self-
renewal activity and mediate tumor initiation and propagation. The PI3K/Akt/mTOR signaling …

[HTML][HTML] Targeting the PI3K/Akt/mTOR pathway–beyond rapalogs

B Markman, R Dienstmann, J Tabernero - Oncotarget, 2010 - ncbi.nlm.nih.gov
It is well established that the PI3K pathway plays a central role in various cellular processes
that can contribute to the malignant phenotype. Accordingly, pharmacological inhibition of …

PI3K/Akt/mTOR signaling pathway in cancer stem cells

M Ebrahimi, E Nourbakhsh, AZ Hazara… - … -Research and Practice, 2022 - Elsevier
Cancer stem cells (CSCs) as a small subpopulation in tumor bulk are believed to initiate
tumor formation and are responsible for the resistance to cancer therapy. The proliferation …

Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and-independent manners

Q Li, L Zhang, Q Yang, M Li, X Pan, J Xu, C Zhong… - Cell Metabolism, 2023 - cell.com
Metabolic reprogramming plays a crucial role in the development of hepatocellular
carcinoma (HCC). However, the key drivers of metabolic reprogramming underlying HCC …

Role of the mammalian target of rapamycin pathway in liver cancer: from molecular genetics to targeted therapies

X Lu, P Paliogiannis, DF Calvisi, X Chen - Hepatology, 2021 - Wiley Online Library
Primary liver cancers, including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (iCCA), are highly lethal tumors, with high worldwide frequency and …

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression

G Hu, Z Yan, C Zhang, M Cheng, Y Yan… - Journal of Experimental …, 2019 - Springer
Abstract Background Forkhead box M1 (FOXM1) is a proliferation-associated transcription
factor of the forkhead box proteins superfamily, which includes four isoforms FOXM1a, b, c …